“Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease” has been published in the journal Molecular Neurobiology. This work was supported in part by JPND through the DEMTEST project, selected in the 2011 biomarkers call.

3 Prill, 2017